Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

  141,861,898      
Direct Value   $82,119,756    

Indirect Value

  $12,961,771,173      
Total Shares   142,789,105      
Total Value   $13,043,890,929      


Incyte Corp
 $32,589,847 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $312,474 Neurogene
 $16,634 Incyte Corp
 $32,589,847 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $312,474 Neurogene
 $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    36   
    6    

     Stock price went up :

    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

Download
  Page 51 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
GHDX Genomic Health Inc Director   –       •       •   2012-05-21 4 B $32.04 $4,826,973 I/I 150,000 246,683 2.25 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2009-06-01 4 S $3.86 $593,536 I/I (153,371) 3,831,534 0 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2006-12-22 4 B $3.85 $595,557 I/I 154,646 771,212 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-05 4 B $29.96 $4,651,479 I/I 155,014 8,213,837 2.25 -
KOD Kodiak Sciences Inc. Director   –       •       •   2022-05-27 4 B $6.64 $1,071,030 I/I 155,940 15,455,507 2.25 %
GHDX Genomic Health Inc Director   –       •       •   2008-06-06 4 B $20.01 $3,212,600 I/I 159,010 3,427,082 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2011-11-02 4 A $0.00 $0 I/I 159,391 220,692 0 -
GHDX Genomic Health Inc Director   –       •       •   2012-02-10 4 B $26.52 $4,249,931 I/I 159,832 7,319,618 2.25 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2003-10-06 4 B $10.80 $1,759,320 I/I 162,900 182,834 1.5 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2007-06-11 4 OE $1.03 $171,196 I/I 165,727 1,172,221 0 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-06-27 4 S $15.41 $2,556,118 I/I (165,874) 300,892 0 -
KOD Kodiak Sciences Inc. Director   –       •       •   2022-06-02 4 B $7.51 $1,274,594 I/I 166,232 15,604,214 2.25 %
GHDX Genomic Health Inc Director   –       •       •   2007-03-09 4 B $18.28 $3,081,430 I/I 168,560 1,738,099 2.25 -
SGEN Seagen Inc Director   –       •       •   2011-08-23 4 B $14.60 $2,528,388 I/I 171,009 13,652,467 2.25 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2003-10-06 4 B $10.80 $1,858,140 I/I 172,050 195,162 1.5 -
GEVA Synageva BioPharma Corp Director   –       •       •   2011-11-02 4 A $0.00 $0 I/I 174,716 206,800 0 -
INCY Incyte Corp Director   –       •       •   2010-09-23 4 S $14.86 $2,669,654 I/I (179,644) 7,511,046 0 -
INCY Incyte Corp Director   –       •       •   2011-12-09 4 B $13.19 $2,402,409 I/I 181,201 11,887,544 2.25 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2008-12-19 4 B $11.14 $2,058,449 I/I 184,780 1,646,964 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2012-02-16 4 B $28.96 $5,499,497 I/I 184,980 7,592,527 2.25 -
ADLR Adolor Corp 10% Owner   –       –       •   2011-12-19 4 D $4.25 $791,656 I/I (186,272) 0 0 -
GEVA Synageva BioPharma Corp Director   –       •       •   2012-01-05 4 A $25.18 $4,723,164 I/I 187,576 1,736,065 0 -
INCY Incyte Corp Director   –       •       •   2008-01-08 4 B $10.00 $2,069,012 I/I 190,709 2,984,789 2.25 -
SGEN Seagen Inc Director   –       •       •   2006-08-09 4/A B $4.05 $791,152 I/I 195,347 4,002,322 2.25 -
SGEN Seagen Inc Director   –       •       •   2006-08-09 4 B $4.05 $791,152 I/I 195,347 3,978,746 2.25 -

  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51  52   53   54   55   56      
  Page 51 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed